Deutsche Märkte geschlossen

Edwards Lifesciences Corporation (EW)

NYSE - Nasdaq Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
92,13-2,24 (-2,37%)
Ab 02:40PM EDT. Markt geöffnet.

Edwards Lifesciences Corporation

One Edwards Way
Irvine, CA 92614
United States
949 250 2500
https://www.edwards.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter15.700

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Michael A. MussallemChairman & CEO2,88M64,1M1953
Mr. Scott B. UllemCorp. VP & CFO1,32MN/A1967
Mr. Donald E. Bobo Jr.Corp. VP of Strategy & Corp. Devel.1,26M11,63M1962
Mr. Larry L. WoodCorp. VP of Transcatheter Aortic Valve Replacement1,31M5,51M1966
Mr. Jean-Luc LemercierCorp. VP of Europe, Middle East, Africa, Canada & Latin America1,43M4,89M1957
Dr. Todd J. BrintonCorp. VP of Advanced Technology & Chief Scientific OfficerN/AN/AN/A
Mark WilterdingVP of Investor RelationsN/AN/AN/A
Mr. Arnold A. PinkstonCorp. VP & Gen. CounselN/AN/A1959
Mr. Dirksen J. LehmanCorp. VP of Public AffairsN/AN/AN/A
Ms. Christine Z. McCauleyCorp. VP of HRN/AN/A1965
Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Corporate Governance

Edwards Lifesciences Corporations ISS Governance QualityScore, Stand 1. Mai 2022, lautet 3. Die grundlegenden Scores sind Audit: 2, Vorstand: 6, Shareholderrechte: 3, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.